REVIEW OF THE COX HEMATOTOXICITY MODEL

By Heaney Mark L.   Nimer Stephen D.  

Journal of Toxicology and Environmental Health, Vol. 61, Iss. 5-6, 2000-11 ,pp. : 539-541

Taylor & Francis Ltd

Access to resources Recommend Favorite

COMMENTS ON THE COX MODEL OF CYCLOPHOSPHAMIDE HEMATOTOXICITY

By Krishnan Kannan  

Journal of Toxicology and Environmental Health, Vol. 61, Iss. 5-6, 2000-11 ,pp. : 511-514

Taylor & Francis Ltd

Access to resources Recommend Favorite

Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Drug: A Review

By Del Tacca M.   Colucci R.   Fornai M.   Blandizzi C.  

Clinical Drug Investigation, Vol. 22, Iss. 12, 2002-01 ,pp. : 799-818

Adis International

Access to resources Recommend Favorite

Cyclo-Oxygenase (COX) Inhibiting Nitric Oxide Donating (CINODs) Drugs: A Review of Their Current Status

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 3, 2007-02 ,pp. : 277-282

Bentham Science Publishers

Access to resources Recommend Favorite

The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment

By Lima-Rodrigues Manuel   Lamas Nuno   Valle-Fernandes Ana   Cruz Andrea   Vieira Artur   Oliveira Pedro   Pedrosa Jorge   Castro António   Reis Rui   Baltazar Fátima   Almeida Armando  

Inflammation Research, Vol. 59, Iss. 9, 2010-09 ,pp. : 743-753

Springer Publishing Company

Access to resources Recommend Favorite